Home/ Stocks/ RXST

RxSight, Inc. Common Stock

RXST XNAS

$6.26 +0.18 (+2.96%) ▲ 15-min delayed

Open

$6.03

High

$6.29

Low

$5.94

Volume

627.7K

Market Cap

$252.89M

About RxSight, Inc. Common Stock

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

Sector: OPHTHALMIC GOODS Employees: 461 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$33.74M	$-12,097,000	$-0.29
Q1 2026	$30.89M	$-15,884,000	$-0.38
FY 2025	$134.48M	$-38,944,000	$-0.95
Q3 2025	$30.34M	$-9,816,000	$-0.24

Related Market News

No specific coverage for RXST yet. Check out our latest market news or earnings calendar.

Get RXST Alerts

Stay ahead with breaking news, price alerts, and expert analysis on RxSight, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.